Fig 6 - by Paulina Kania-Olejnik (19797617)

Expression of 5-HT_4(b), 5-HT_2A, 5-HT_2B and 5-HTT mRNA in left ventricular myocardium. by Trond Brattelid (290970)

“…(A) 5-HT_4(b) mRNA levels decreased with foetal and neonatal development and the level in adult myocardium was one tenth of that at day -3 but reappeared in HF; (B) 5-HT_2A mRNA expression increased at birth (day 1), decreased during neonatal development and was unaltered in HF; (C) 5-HT_2B mRNA expression was transiently increased at birth (day 1) compared to adult (day 113) and not changed in HF; (D) 5-HTT mRNA expression was lower in foetal hearts compared to neonatal, adult, Sham and HF which all showed a similar expression level. …”

DataSheet1_PagSOD2a improves poplar salt tolerance by elevating superoxide dismutase activity and decreasing malondialdehyde contents.zip by Lieding Zhou (16427928)

Table_5_Arabidopsis Histone Methyltransferase SUVH5 Is a Positive Regulator of Light-Mediated Seed Germination.DOCX by Dachuan Gu (6790856)

“…Here, we identified SUVH5, a histone H3 lysine 9 methyltransferase, as a positive regulator in light-mediated seed germination in Arabidopsis. …”

Expression of individual SNARE complex proteins partially rescues <i>rpS13/+</i> developmental delay. by Lisa Patricia Deliu (13570709)

T0 treatment significantly decreased soluble Aβ oligomers, but not amyloid plaque pathology in APP/E4/Abca1^+/- mice. by Alexis Y. Carter (3798223)

“…N = 5–6 mice per group. N.S., not significant. <b>E,</b> T0 treatment significantly decreases Aβ oligomers in APP/E4/Abca1^+/- mice. …”

Image5_Analysis of Geometric and Hemodynamic Profiles in Rat Arteriovenous Fistula Following PDE5A Inhibition.tif by Hannah Northrup (5938436)

“…Geometrical parameters include arterial-venous (A-V) distance, anastomosis angle, tortuosity, and nonplanarity angle magnitude. …”

Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner by Khondoker Alam (1443499)

“…Compared with vehicle control treatment, bortezomib pretreatment significantly decreased the maximal transport velocity (V_max) of OATP1B3-mediated transport of CCK-8 (92.25 ± 14.2 vs. 133.95 ± 15.5 pmol/mg protein/min) without affecting the affinity constant (K_m) values. …”

Serum Creatinine Modifies Associations between Body Mass Index and Mortality and Morbidity in Prevalent Hemodialysis Patients by Yukitoshi Sakao (2547880)

Subjects:

Multivariate-adjusted odds ratios for the cause-specific mortality (A: cardiac death, B: cerebrovascular death, C: infection-related death, D: cancer-related death) according to BM... by Yukitoshi Sakao (2547880)

Subjects:

Multivariate-adjusted odds ratios for all-cause mortality according to BMI categories. by Yukitoshi Sakao (2547880)

Subjects:

Multivariate-adjusted odds ratios for the cause-specific mortality (A: cardiac death, B: cerebrovascular death, C: infection-related death, D: cancer-related death) according to BM... by Yukitoshi Sakao (2547880)

Subjects:

Associations of BMI with morbidities according to Cr levels in female. by Yukitoshi Sakao (2547880)

Subjects:

Patient selection. by Yukitoshi Sakao (2547880)

Subjects:

Baseline characteristics of the study cohort. by Yukitoshi Sakao (2547880)

Subjects:

Associations of BMI with morbidities according to Cr levels in male. by Yukitoshi Sakao (2547880)

Subjects:

Multivariate-adjusted odds ratios for all-cause mortality according to the BMI groups and the tertiles of serum Cr. by Yukitoshi Sakao (2547880)

Subjects:

Raw images of all western blots presented in the lower panel of Fig 2A. by Xianghong Kuang (17811238)

Raw images of all western blots presented in the upper panel of Fig 2A. by Xianghong Kuang (17811238)

Expression of miR-34a-5p is up-regulated in human colorectal cancer and correlates with survival and clock gene <i>PER2</i> expression by Kristina Hasakova (7553306)

“…From <i>in silico</i> analysis, miR-34a-5p was selected as showing a computer-predicted interaction with <i>PER2</i>. …”